Skip to main content

Use of Mouse JB6 Cells to Identify Molecular Targets and Novel Agents for Prevention of Carcinogenesis

  • Conference paper
Food Factors for Cancer Prevention

Summary

Identification of the natural or synthetic agents that block the rate-limiting phase of tumor promotion is essential to the goal of cancer prevention. In vitro model systems to study the promotion process and to screen potential preventive agents continue to be important. One well established system representing preneoplastic to neoplastic progression is the JB6 murine epidermal model, which consists of promotion-resistant (P-) and promotion-sensitive (P+) preneoplastic cell lines as well as irreversibly transformed, tumorigenic cell lines. The model has been used to study the molecular mechanisms of tumor promotion, identify potential promoters and promotion inhibitors, elucidate differences between neoplastic and preneoplastic cells (e.g., identification of genes required for maintenance of tumor phenotype), and evaluate agents for reversion potential. Additionally, apoptosis response variants of one of the tumorigenic JB6 lines allow the study of programmed cell death, a process important to the prevention of or susceptibility to carcinogenesis. Exogenous promoters such as the phorbol esters and endogenous promoters such as epidermal growth factor, transforming growth factor, and tumor necrosis factor induce the anchorage-independent transformation of P+ cells. The antipromoting activity of a number of agents having cancer prevention potential has been demonstrated using P+ cells. These agents include classic antipromoters such as retinoic acid and food factors such as green or black tea and curcumin. Important insights into the mechanism of neoplastic transformation have been gained from comparison of JB6 P+ and P- cells, most notably the requirement for induction of transcription factor AP-1 transactivation activity. This understanding has led to the development of small molecule and transgene agents aimed at specifically blocking AP-1 activity; they are under evaluation for their ability to block cancer development.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Boutwell RK (1974) The function and mechanism of promoters of carcinogenesis. CRC Crit Rev Toxicol 2:419–443

    Article  PubMed  CAS  Google Scholar 

  2. Berenblum I (1978) Historical perspective. In: Slaga TJ, Sivak A, Boutwell RK (eds) Carcinogenesis, vol 2: Mechanisms of tumor promotion and cocarcinogenesis. Raven, New York, pp 1–10

    Google Scholar 

  3. Vogelstein B, Kinzler KW (1993) The multistep nature of cancer. Trends Genet 9:138–141

    Article  PubMed  CAS  Google Scholar 

  4. Gould MN (1993) Cellular and molecular aspects of the multistage progression of mammary carcinogenesis in humans and rats. Semin Cancer Biol 4:161–169

    PubMed  CAS  Google Scholar 

  5. Reznikoff CA, Kao C, Messing EM, Newton M, Swaminathan S (1993) A molecular genetic model of human bladder carcinogenesis. Semin Cancer Biol 4:143–152

    PubMed  CAS  Google Scholar 

  6. Slaga TJ, Fischer SM, Nelson K, Gleason GL (1980) Studies on the mechanism of skin tumor promotion: evidence for several stages of promotion. Proc Natl Acad Sci USA 77:3659–3663

    Article  PubMed  CAS  Google Scholar 

  7. Strickland JE, Greenhalgh DA, Koceva-Chyla A, Hennings H, Restrepo C, Balaschak M, Yuspa SH (1988) Development of murine epidermal cell lines which contain an activated ras Ha oncogene and form papillomas in skin grafts on athymic nude mouse hosts. Cancer Res 48:165–169

    PubMed  CAS  Google Scholar 

  8. Colburn NH, Vorder Bruegge WF, Bates JR, Gray RH, Rossen JD, Kelsey WH, Shimada T (1978) Correlation of anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cells. Cancer Res 38:624–634

    PubMed  CAS  Google Scholar 

  9. Colburn NH, Former BF, Nelson KA, Yuspa SH (1979) Tumour promoter induces anchorage independence irreversibly. Nature 282:589–591

    Article  Google Scholar 

  10. Colburn NH, Koehler BA, Nelson KJ (1980) A cell culture assay for tumor-promoter-dependent progression toward neoplastic phe-notype: detection of tumor promoters and promotion inhibitors. Teratogen Carcinogen Mutagen 1:87–96

    Article  CAS  Google Scholar 

  11. Colburn NH (1980) Tumor promoter produces anchorage independence in mouse epidermal cells by an induction mechanism. Carcinogenesis 1:951–954

    Article  PubMed  CAS  Google Scholar 

  12. Colburn NH, Wendel EJ, Abruzzo G (1981) Dissociation of mitogenesis and late-stage promotion of tumor cell phenotype by phorbol esters: mitogen-resistant variants are sensitive to promotion. Proc Natl Acad Sci USA 78:6912–6916

    Article  PubMed  CAS  Google Scholar 

  13. Kume K, Jinno S, Miwatani H, Kizaka-Kondoh S, Terada Y, Nojima H, Okayama H (1992) Oncogenic signal-induced ability to enter S phase in the absence of anchorage is the mechanism for the growth of transformed NRK cells in soft agar. New Biol 4:504–511

    PubMed  CAS  Google Scholar 

  14. Enomoto T, Asano Y (1994) Differential susceptibility of morphologically TPA-resistant and -sensitive Balb/c 3T3 variants to TPA-induced cell transformation: relationship to induction of membrane ruffling. Cell Struct Funct 19:227–239

    Article  PubMed  CAS  Google Scholar 

  15. Colburn NH, Lerman MI, Srinivas L, Nakamura Y, Gindhart TD (1984) Membrane and genetic events in tumor promotion: studies with promoter resistant variants of JB6 cells. In: Fujiki H (ed) Cellular interactions by environmental tumor promoters. Japan Science Society Press, Tokyo/VNU Science Press, Utrecht, pp 155–166

    Google Scholar 

  16. Dong Z, Cmarik JL, Wendel EJ, Colburn NH (1994) Differential transformation efficiency but not AP-1 induction under anchorage-dependent and -independent conditions. Carcinogenesis 15:1001–1004

    Article  PubMed  CAS  Google Scholar 

  17. Sun Y, Pommier Y, Colburn NH (1992) Acquisition of a growth-inhibitory response to phorbol esters involves DNA damage. Cancer Res 52:1907–1915

    PubMed  CAS  Google Scholar 

  18. Singh N, Sun Y, Nakamura K, Smith MR, Colburn NH (1995) c-Jun/AP-1 as possible mediators of TNF-induced apoptotic response in transformed mouse JB6 cells. Oncol Res 7:353–362

    PubMed  CAS  Google Scholar 

  19. Li J-J, Dong Z, Dawson MI, Colburn NH (1996) Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element. Cancer Res 56:483–489

    PubMed  CAS  Google Scholar 

  20. Colburn NH, Gindhart TD (1981) Specific binding of transforming growth factor correlates with promotion of anchorage independence in EGF receptorless mouse JB6 cells. Biochem Biophys Res Commun 102:799–807

    Article  PubMed  CAS  Google Scholar 

  21. Wilder PJ, Rizzino A (1991) Effects of transforming growth factor ß on the anchorage-independent growth of murine epithelial JB6 cells. Cancer Res 51:5898–5902

    PubMed  CAS  Google Scholar 

  22. De Benedetti F, Colburn NH, Oppenheim JJ, Faltynek CR (1990) Tumor necrosis factor induces anchorage independent growth of two murine nontransformed cell lines. In: Oppenheim JJ, Powanda M, Kluger M, Dinarello C (eds) Molecular and cellular biology of cytokines. Wiley-Liss, New York, pp 275–280

    Google Scholar 

  23. De Benedetti F, Falk L, Ruscetti FW, Colburn NH, Faltynek CR, Oppenheim JJ (1991) Synergistic inhibition of phorbol ester-induced transformation of JB6 cells by transforming growth fac-tor-ß and retinoic acid. Cancer Res 51:1158–1164

    PubMed  Google Scholar 

  24. Hosoi J, Abe E, Suda T, Colburn NH, Kuroki T (1986) Induction of anchorage-independent growth of JB6 mouse epidermal cells by la,25-dihydroxyvitamin D3. Cancer Res 46:5582–5586

    PubMed  CAS  Google Scholar 

  25. Chang P-L, Prince CW (1991) 1α,25-Dihydroxyvitamin D3 stimulates synthesis and secretion of nonphosphorylated osteopontin (secreted phosphoprotein 1) in mouse JB6 epidermal cells. Cancer Res 51:2144–2150

    PubMed  CAS  Google Scholar 

  26. Chang P-L, Prince CW (1993) 1α,25-Dihydroxyvitamin D3 enhances 12-O-tetradecanoylphorbol-13-acetate-induced tumo-rigenic transformation and osteopontin expression in mouse JB6 epidermal cells. Cancer Res 53:2217–2220

    PubMed  CAS  Google Scholar 

  27. Gindhart TD, Nakamura Y, Stevens LA, Hegamyer GA, West MA, Smith BM, Colburn NH (1985) Genes and signal transduction in tumor promotion: conclusions from studies with promoter resistant variants of JB-6 mouse epidermal cells. In: Mass MJ, Kaufman DG, Siegfried JM, Steele VE, Nesnow S (eds) Carcinogenesis, vol 8: Cancer of the respiratory tract: predisposing factors. Raven, New York, pp 341–367

    Google Scholar 

  28. Smith BM, Gindhart TD, Colburn NH (1986) Possible involvement of a lanthanide-sensitive protein kinase C substrate in lanthanide promotion of neoplastic transformation. Carcinogenesis 7:1949–1956

    Article  PubMed  CAS  Google Scholar 

  29. Srinivas L, Colburn NH (1984) Preferential oxidation of cell surface sialic acid by periodate leads to promotion of transformation in JB6 cells. Carcinogenesis 5:515–519

    Article  PubMed  CAS  Google Scholar 

  30. Gindhart TD, Srinivas L, Colburn NH (1985) Benzoyl peroxide promotion of transformation of JB6 mouse epidermal cells: inhibition by ganglioside G, but not retinoic acid. Carcinogenesis 6:309–311

    Article  PubMed  CAS  Google Scholar 

  31. Nakamura Y, Gindhart TD, Winterstein D, Tomita I, Seed JL, Colburn NH (1988) Early superoxide dismutase-sensitive event promotes neoplastic transformation in mouse epidermal JB6 cells. Carcinogenesis 9:203–207

    Article  PubMed  CAS  Google Scholar 

  32. Garrett LR, Ackland-Berglund CE, Jones CJ, Cuchens MA (1993) Differential effects of TPA and pristane on gene expression and transformation in mouse epidermal cells. Exp Cell Res 205:416–421

    Article  PubMed  CAS  Google Scholar 

  33. Kraft AS, Reeves JA, Ashendel CL (1988) Differing modulation of protein kinase C by Bryostatin 1 and phorbol esters in JB6 mouse epidermal cells. J Biol Chem 263:8437–8442

    PubMed  CAS  Google Scholar 

  34. Hosoi J, Kato K, Kuroki T (1987) Induction of anchorage-independent growth of mouse JB6 cells by cholera toxin. Carcinogenesis 8:377–380

    Article  PubMed  CAS  Google Scholar 

  35. Diwan BA, Ward JM, Rice JM, Colburn NH, Spangler EF (1985) Tumor-promoting effects of di(2-ethylhexyl)phthalate in JB6 mouse epidermal cells and mouse skin. Carcinogenesis 6:343–347

    Article  PubMed  CAS  Google Scholar 

  36. West RW, Hinson WG, Lyle DB, Swicord ML (1994) Enhancement of anchorage-independent growth in JB6 cells exposed to 60 hertz magnetic fields. Bioelectrochem Bioenerget 34:39–43

    Article  Google Scholar 

  37. Colburn NH, Ozanne S, Lichti U, Ben T, Yuspa SH, Wendel E, Jardini E, Abruzzo G (1981) Retinoids inhibit promoter-dependent preneoplastic progression in mouse epidermal cell lines. Ann NY Acad Sci 359:251–259

    Article  PubMed  CAS  Google Scholar 

  38. Colburn NH (1985) Genes and membrane signals involved in neoplastic transformation. In: Huberman E, Barr SH (eds) Carcinogenesis, vol 10: The role of chemicals and radiation in the etiology of cancer. Raven, New York, pp 235–248

    Google Scholar 

  39. Dong Z, Birrer MJ, Watts RG, Matrisian LM, Colburn NH (1994) Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc Natl Acad Sci USA 91:609–613

    Article  PubMed  CAS  Google Scholar 

  40. Colburn NH, Smith BM, Wendel EJ, Nakamura Y, Winterstein D (1988) Comparison of mouse pro-1 and pro-2 transfectants for responses to tumor promoters and antipromoters. Cancer Res 48:6076–6080

    PubMed  CAS  Google Scholar 

  41. Smith JS, Wey HE, Leikauf GD, Baxter CS (1992) Carba-prostacyclin inhibits 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced transformation in sensitive murine epidermal JB6 cells. Carcinogenesis 13:1859–1862

    Article  PubMed  CAS  Google Scholar 

  42. Nakamura Y, Colburn NH, Gindhart TD (1985) Role of reactive oxygen in tumor promotion: implication of superoxide anion in promotion of neoplastic transformation in JB-6 cells by TPA. Carcinogenesis 6:229–235

    Article  PubMed  CAS  Google Scholar 

  43. Ludwig A, Dietel M, Schäfer G, Muller K, Hilz H (1990) Nicotinamide and nicotinamide analogues as antitumor promoters in mouse skin. Cancer Res 50:2470–2475

    PubMed  CAS  Google Scholar 

  44. Nakamura Y, Harada S, Shimoi K, Oguni I, Tomita I (1987) Study on the antimutagenic and antipromoting effects of tea extracts. In: The Tea Research Institute (eds) Proceedings of international tea quality-human health symposium. Chinese Academy of Agricultural Sciences, Hangzhou, pp 227–238

    Google Scholar 

  45. Oguni I, Tomita I, Nakamura Y (1988) Some evidence that the green tea may play a role in the prevention of tumor developments. In: Proceedings of the international symposium on recent development in tea production. Taiwan Tea Experiment Station, Yangmei, Taoyuan, Taiwan, pp 281–298

    Google Scholar 

  46. Nakamura Y, Harada S, Kawase I, Matsuda M, Tomita I (1991) Inhibitory effects of tea ingredients on the in vitro tumor promotion of mouse epidermal JB6 cells. In: Proceedings of international symposium on tea science. Organizing Committee of ISTS, Shizuoka, Japan, pp 205–209

    Google Scholar 

  47. Lu Y, Chang RL, Lou Y, Huang M-T, Newmark HL, Reuhl KR, Conney AH (1994) Effect of curcumin on 12-O-tetra-decanoylphorbol-13-acetate- and ultraviolet B light-induced expression of c-Jun and c-Fos in JB6 cells and in mouse epidermis. Carcinogenesis 15:2363–2370

    Article  PubMed  CAS  Google Scholar 

  48. Jhappan C, Takayama H, Dickson RB, Merlino G (1994) Transgenic mice provide genetic evidence that transforming growth factor a promotes skin tumorigenesis via H-Ras- dependent and H-Ras-independent pathways. Cell Growth Differ 5:385–394

    PubMed  CAS  Google Scholar 

  49. Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, Lee DC (1990) Overexpression of TGFa in transgenic mice; induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 61:1121–1135

    Article  PubMed  CAS  Google Scholar 

  50. Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, Merlino GT (1990) TGFa overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61:1137–1146

    Article  PubMed  CAS  Google Scholar 

  51. Matsui Y, Halter SA, Holt JT, Hogan BLM, Coffey RJ (1990) Development of mammary hyperplasia and neoplasia in MMTV-TGFoc transgenic mice. Cell 61:1147–1155

    Article  PubMed  CAS  Google Scholar 

  52. Colburn NH (1979) The use of tumour promoter responsive epidermal cell lines to study preneoplastic progression. In: Franks LM, Wigley CB (eds) Neoplastic transformation in differentiated epithelial cell systems in vitro. Academic, San Diego, pp 113–134

    Google Scholar 

  53. Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330:1029–1035

    Article  Google Scholar 

  54. Peterson K (1996) “Natural” cancer prevention trial halted. Science 271:441

    Article  PubMed  CAS  Google Scholar 

  55. Chambon P (1994) The retinoid signaling pathway: molecular and genetic analyses. Semin Cell Biol 5:115–125

    Article  PubMed  CAS  Google Scholar 

  56. Schule R, Rangarajan P, Yang N, Kliewer S, Ransone LJ, Bolado J, Verma IM, Evans RM (1991) Retinole acid is a negative regulator of AP-1-responsive genes. Proc Natl Acad Sci USA 88:6092–6096

    Article  PubMed  CAS  Google Scholar 

  57. Yang-Yen HF, Zhang XK, Graupner G, Tzukerman M, Sakamoto B, Karin M, Pfahl M (1991) Antagonism between retinoic acid receptors and AP-1: implications for tumor promotion and inflammation. New Biol 3:1206–1219

    PubMed  CAS  Google Scholar 

  58. Rudd CJ, Mansbridge JN, Suing KD, Dawson MI (1993) Correlation of the ability of retinoids to inhibit promoter-induced anchorage-independent growth of JB6 mouse epidermal cells with their activation of retinoic acid receptor y. Cancer Lett 73:41–49

    Article  PubMed  CAS  Google Scholar 

  59. Fanjul A, Dawson MI, Hobbs PD, Jong L, Cameron JF, Harlev E, Graupner G, Lu X-P, Pfahl M (1994) A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature 372:107–110

    Article  PubMed  CAS  Google Scholar 

  60. Dong Z, Lavrovsky V, Colburn NH (1995) Transformation reversion induced in JB6 RT101 cells by AP-1 inhibitors. Carcinogenesis 16:749–756

    Article  PubMed  CAS  Google Scholar 

  61. Huang T-S, Lee S-C, Lin J-K (1991) Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc Natl Acad Sci USA 88:5292–5296

    Article  PubMed  CAS  Google Scholar 

  62. Su L, Mukherjee AB, Mukherjee BB (1995) Expression of antisense osteopontin RNA inhibits tumor promoter-induced neoplastic transformation of mouse JB6 epidermal cells. Oncogene 10:2163–2169

    PubMed  CAS  Google Scholar 

  63. Colburn NH, Gindhart TD, Hegamyer GA, Blumberg PM, Delclos KB, Magun BE, Lockyer J (1982) Phorbol diester and epidermal growth factor receptors in 12–0-tetradecanoylphorbol-13-aceta-teresistant and -sensitive mouse epidermal cells. Cancer Res 42:3093–3097

    PubMed  CAS  Google Scholar 

  64. Smith BM, Colburn NH (1988) Protein kinase C and its substrates in tumor promoter-sensitive and -resistant cells. J Biol Chem 263:6424–6431

    PubMed  CAS  Google Scholar 

  65. Ben-Ari ET, Bernstein LR, Colburn NH (1992) Differential c-jun expression in response to tumor promoters in JB6 cells sensitive or resistant to neoplastic transformation. Mol Carcinog 5:62–74

    Article  PubMed  CAS  Google Scholar 

  66. Cmarik JL, Herschman H, Colburn NH (1994) Preferential primary-response gene expression in promotion-resistant versus promotion-sensitive JB6 cells. Mol Carcinog 11:115–124

    Article  PubMed  CAS  Google Scholar 

  67. Sun Y, Nakamura K, Hegamyer G, Dong Z, Colburn N (1993) No point mutation of Ha-ras or p53 genes expressed in preneoplastic-to-neoplastic progression as modeled in mouse JB6 cell variants. Mol Carcinog 8:49–57

    Article  PubMed  Google Scholar 

  68. Sun Y, Dong Z, Jackman J, Hegamyer G, Kim H, Sithanandam K, Colburn NH (1995) Status of the MDM-2 and WAF-1 genes in mouse epidermal JB6 variants harboring wild-type p53 a p53-independent induction of WAF-1. Int J Oncol 6:465–471

    PubMed  CAS  Google Scholar 

  69. Sun Y, Hegamyer G, Colburn NH (1994) Molecular cloning of five messenger RNAs differentially expressed in preneoplastic or neoplastic JB6 mouse epidermal cells: one is homologous to human tissue inhibitor of metalloproteinases-3. Cancer Res 54:1139–1144

    PubMed  CAS  Google Scholar 

  70. Sun Y, Hegamyer G, Kim H, Sithanandam K, Li H, Watts R, Colburn NH (1995) Molecular cloning of mouse tissue inhibitor of metalloproteinases-3 (mTIMP-3) and its promoter: specific lack of expression in neoplastic JB6 cells may reflect altered gene methy-lation. J Biol Chem 270:19312–19319

    Article  PubMed  CAS  Google Scholar 

  71. Bian J, Wang Y, Smith MR, Kim H, Jacobs C, Jackman J, Kung H-F, Colburn NH, Sun Y (1996) Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3. Carcinogenesis 17:1805–1811

    Article  PubMed  CAS  Google Scholar 

  72. Simek SL, Kligman D, Patel J, Colburn NH (1989) Differential expression of an 80-kDa protein kinase C substrate in preneoplastic and neoplastic mouse JB6 cells. Proc Natl Acad Sci USA 86:7410–7414

    Article  PubMed  CAS  Google Scholar 

  73. Hirano K, Smith BM, Colburn NH (1992) Differential induction of 15 and 16kDa nuclear proteins in promotion sensitive and promotion resistant mouse JB6 cells. Oncol Res 4:17–21

    PubMed  CAS  Google Scholar 

  74. Seed JL, Nakamura Y, Colburn NH (1987) Implication of superoxide radical anion in promotion of neoplastic transformation in mouse JB6 cells by TPA. In: Cerutti PA, Nygaard OF, Simic MG (eds) Anticarcinogenesis and radiation protection. Plenum, New York, pp 175–181

    Chapter  Google Scholar 

  75. Crawford DR, Amstad PA, Yin Foo DD, Cerutti PA (1989) Constitutive and phorbol-myristate-acetate regulated antioxidant defense of mouse epidermal JB6 cells. Mol Carcinog 2:136–143

    Article  PubMed  CAS  Google Scholar 

  76. Singh N, Aggarwal S (1995) The effect of active oxygen generated by xanthine/xanthine oxidase on genes and signal transduction in mouse epidermal JB6 cells. Int J Cancer 62:107–114

    Article  PubMed  CAS  Google Scholar 

  77. Amstad P, Peskin A, Shah G, Mirault M-E, Moret R, Zbinden I, Cerutti P (1991) The balance between Cu,Zn-superoxide dis-mutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress. Biochemistry 30:9305–9313

    Article  PubMed  CAS  Google Scholar 

  78. Amstad P, Moret R, Cerutti P (1994) Glutathione peroxidase compensates for the hypersensitivity of Cu,Zn-superoxide dismutase overproducers to oxidant stress. J Biol Chem 269:1606–1609

    PubMed  CAS  Google Scholar 

  79. Muehlematter D, Larsson R, Cerutti P (1988) Actie oxygen induced DNA strand breakage and poly ADP-ribosylation in promotable and nonpromotable JB6 mouse epidermal cells. Carcinogenesis 9:239–245

    Article  PubMed  CAS  Google Scholar 

  80. Jain PT, Chang SH, Berezesky IK, Amstad P, Cerutti PA, Trump BF (1994) Differential cytotoxicity in mouse epidermal JB6 cells: a potential mechanism for oxidant tumor promotion. Mol Carcinog 11:164–169

    Article  PubMed  CAS  Google Scholar 

  81. Smith JS, Wey HE, Leikauf GD, Baxter CS (1992) JB6 murine epidermal cell lines sensitive and resistant to 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced transformation exhibit differential arachidonic acid metabolism in response to TPA and the calcium ionophore A23187. Carcinogenesis 13:189–192

    Article  PubMed  CAS  Google Scholar 

  82. Smith BM, Gindhart TD, Colburn NH (1986) Extracellular calcium requirement for promotion of transformation in JB6 cells. Cancer Res 46:701–706

    PubMed  CAS  Google Scholar 

  83. Denhardt DT, Guo X (1993) Osteopontin: a protein with diverse functions. FASEB J 7:1475–1482

    PubMed  CAS  Google Scholar 

  84. Smith JH, Denhardt DT (1987) Molecular cloning of a tumor promoter-inducible mRNA found in JB6 mouse epidermal cells: induction is stable at high, but not at low, cell densities. J Cell Biochem 34:13–22

    Article  PubMed  CAS  Google Scholar 

  85. Chang P-L, Ridall AL, Prince CW (1994) Calcitriol regulation of osteopontin expression in mouse epidermal cells. Endocrinology 135:863–869

    Article  PubMed  CAS  Google Scholar 

  86. Behrend EI, Craig AM, Wilson SM, Denhardt DT, Chambers AF (1994) Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Cancer Res 54:832–837

    PubMed  CAS  Google Scholar 

  87. Cardner HAR, Berse B, Senger DR (1994) Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Rati fibroblasts. Oncogene 9:2321–2326

    Google Scholar 

  88. Bernstein LR, Colburn NH (1989) AP-1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science 244:566–569

    Article  PubMed  CAS  Google Scholar 

  89. Bernstein LR, Bravo R, Colburn NH (1992) 12-O-Tetra-decanoylphorbol-13-acetate-induced levels of AP-1 proteins: a 46-kDa protein immunoprecipitated by anti-fra-1 and induced in promotion-resistant but not promotion-sensitive JB6 cells. Mol Carcinog 6:221–229

    Article  PubMed  CAS  Google Scholar 

  90. Watts RG, Ben-Ari ET, Bernstein LR, Birrer MJ, Winterstein D, Wendel E, Colburn NH (1995) c-jun and multistage carcinogenesis: association of overexpression of introduced c-jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter-induced transformation. Mol Carcinog 13:27–36

    Article  PubMed  CAS  Google Scholar 

  91. Steinberg J (1996) Edible-vaccine trial: no small potatoes. J NIH Res 8:26–28

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Japan

About this paper

Cite this paper

Cmarik, J.L., Colburn, N.H. (1997). Use of Mouse JB6 Cells to Identify Molecular Targets and Novel Agents for Prevention of Carcinogenesis. In: Ohigashi, H., Osawa, T., Terao, J., Watanabe, S., Yoshikawa, T. (eds) Food Factors for Cancer Prevention. Springer, Tokyo. https://doi.org/10.1007/978-4-431-67017-9_13

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-67017-9_13

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-67019-3

  • Online ISBN: 978-4-431-67017-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics